GLAXOSMITHKLINE PLC

GSK
Real-time Estimate Quote. Real-time Estimate  - 08/07 05:17:41 am
1547.8GBX -0.14%
Prev.1550.0000
Open1557.0000
High1566.0350
Low1549.4000
Volume528 830
Latest news
1m ago
1d ago
1d ago
1d ago
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance1 5991 7421 846
Spread/Res.-3,1%-11%-16%
Spread/Supp.1,4%13%11%
Support1 5291 3751 403
Financials
Sales 2020 35 121 M 46 034 M 46 034 M
Net income 2020 4 615 M 6 049 M 6 049 M
Net Debt 2020 23 344 M 30 597 M 30 597 M
P/E ratio 2020 15,5x
Yield 2020 5,16%
Capitalization 77 141 M 101 B 101 B
EV / Sales 2020 2,86x
EV / Sales 2021 2,71x
Nbr of Employees 99 437
Free-Float 91,2%
Company
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (52%): intended for respiratory diseases (67.5% of net sales), HIV infection (27.7%), immune system disorders (3.5%) ) and cancer (1,3%);
- OTC and...
Sector :
Pharmaceuticals - NEC
Calendar :
2020-08-13 GLAXOSMITHKLINE PLC : Ex-dividend day for interim dividend
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 1 872,93 GBX
Last Close Price 1 550,00 GBX
Spread / Highest target 44,5%
Spread / Average Target 20,8%
Spread / Lowest Target -0,84%